Showing results (1-10 of 5,995) with videos related to
Sort By:
Pageof 600
Neuro-Oncology|July 19, 2015
Isocitrate dehydrogenase mutations in gliomasMatthew S Waitkus, Bill H Diplas, Hai YanCancer Cell|May 29, 2018
Biological Role and Therapeutic Potential of IDH Mutations in CancerMatthew S Waitkus, Bill H Diplas, Hai YanClinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 5, 2020
Targeting Isocitrate Dehydrogenase Mutations in Cancer: Emerging Evidence and Diverging StrategiesMatthew S Waitkus, Hai YanMolecular Cancer Research : MCR|July 12, 2019
CRISPR Editing of Mutant IDH1 R132H Induces a CpG Methylation-Low State in Patient-Derived Glioma Models of G-CIMPCasey J Moure, Bill H Diplas, Lee H Chen, et al.Acta Neuropathologica Communications|November 4, 2021
TP53 wild-type/PPM1D mutant diffuse intrinsic pontine gliomas are sensitive to a MDM2 antagonistCheng Xu, Heng Liu, Christopher J Pirozzi, et al.Communications Biology|November 10, 2023
Mining cancer genomes for change-of-metabolic-function mutationsKevin J Tu, Bill H Diplas, Joshua A Regal, et al.Neuro-Oncology|October 23, 2018
Sensitive and rapid detection of TERT promoter and IDH mutations in diffuse gliomasBill H Diplas, Heng Liu, Rui Yang, et al.Molecular Cancer Research : MCR|April 2, 2020
Targeting Mutant PPM1D Sensitizes Diffuse Intrinsic Pontine Glioma Cells to the PARP Inhibitor OlaparibZhaohui Wang, Cheng Xu, Bill H Diplas, et al.Cancer Research|September 24, 2017
<i>Cic</i> Loss Promotes Gliomagenesis via Aberrant Neural Stem Cell Proliferation and DifferentiationRui Yang, Lee H Chen, Landon J Hansen, et al.Neuro-Oncology|January 23, 2023
Cancer-associated SMARCAL1 loss-of-function mutations promote alternative lengthening of telomeres and tumorigenesis in telomerase-negative glioblastoma cellsHeng Liu, Cheng Xu, Bill H Diplas, et al.Pageof 600